Plexāā launches Bloom43 wearable breast surgery prep device
October 3, 2025
Plexāā announced that it launched its Bloom43 wearable preconditioning medical device for breast surgery in the U.S.
Plexāā announced that it launched its Bloom43 wearable preconditioning medical device for breast surgery in the U.S.
IceCure Medical (Nasdaq:ICCM) announced today that the FDA granted marketing authorization for its ProSense cryoablation system for breast cancer.
In 2020, right when Jane Baude was starting her Ph.D. research at UC Santa Barbara, she learned that a critical component of her experiment—the gel needed to grow and test mammary epithelial cells—wouldn’t be available for nearly a year because of pandemic-related production issues. So, she and her advisor, professor Ryan Stowers, decided to pivot: Baude would engineer her own gel to study cells.
Aspivix, a FemTech company specialising in the modernisation of gynaecological care, has announced the official launch of its breakthrough device, carevix, now available to healthcare professionals in Southern California and New York State.
Distalmotion announced today that it received FDA 510(k) clearance for the use of its Dexter robotic surgery system in hysterectomy.
The investigational drug elinzanetant significantly reduces hot flashes and night sweats for postmenopausal women, a large, international clinical trial has found.
By 3D bioprinting miniature placentas, scientists have provided a new way to study complications in pregnancy, with the research led by the University of Technology Sydney (UTS).
An AI algorithm based only on routine mammogram images plus age can predict a woman’s risk of major cardiovascular disease as well as standard risk assessment methods, finds research published online in the journal Heart.
SAN FRANCISCO, Sept. 9, 2025 /PRNewswire/ — Willow Innovations, Inc. (Willow), the Femtech leader and inventor of the first fully in-bra wearable breast pump, is once again revolutionizing the pumping experience with the launch of its newest innovation.
Suicide is a leading cause of death in postpartum women—and it is a preventable one. It is estimated that nearly half of mothers experiencing perinatal depression are undiagnosed and are not receiving treatment. But when women are given vital mental health tools in an accessible manner, their deaths can be prevented.